From Sample to Insight: Advanced Analytics for Oncology Research
Modern oncology research requires precise and comprehensive analyses that transform biological samples into valuable insights. This presentation will showcase how specialized laboratory services support the development of cancer therapies and diagnostics, leveraging advanced analytical technologies to analyze metabolites, biomarkers, proteins, and other key molecular indicators present in biological samples.
Contemporary research increasingly relies on comprehensive, multi-level analytical approaches that help to better understand molecular processes occurring in biological systems. Such integrated strategies support the identification of important molecular patterns and contribute to the progress of biomedical and translational research in oncology.
TBC
Show more
TBC
Malwina Woźniak
Malwina graduated in biotechnology from Wrocław University of Science and Technology and subsequently gained experience at a CRO company in the field of Drug Discovery. She specializes in the bioanalysis of small-molecule compounds, with a particular focus on ADME analysis and has extensive experience in conducting high-throughput analyses using a range of LC-MS/MS systems.
She is also specialist in the optimization, validation, and transfer of bioanalytical methods, with experience in managing research and development projects and collaborating with external clients. Since 2024, Malwina has been working at Łukasiewicz – PORT, where she works at the interface of science and business, actively fostering new partnership opportunities.
More about Malwina Woźniak.
Malwina graduated in biotechnology from Wrocław University of Science and Technology and subsequently gained experience at a CRO company in the field of Drug Discovery. She specializes in the bioanalysis of small-molecule compounds, with a particular focus on ADME analysis and has extensive experience in conducting high-throughput analyses using a range of LC-MS/MS systems.
Show more
She is also specialist in the optimization, validation, and transfer of bioanalytical methods, with experience in managing research and development projects and collaborating with external clients. Since 2024, Malwina has been working at Łukasiewicz – PORT, where she works at the interface of science and business, actively fostering new partnership opportunities.
Read the Abstracts from Our Invited Speakers
Cancer Biology
- AllergoOncology: Lessons Learned from the Allergy-Glioblastoma Connection
Aurélie Poli, Luxembourg Institute of Health, LUXEMBOURG
- Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype
Joanna Poźniak, KU Leuven, BELGIUM
- Inducing Immunogenic Tertiary Lymphoid Structures Across Cancer Types With Dendritic Cell Reprogramming
Camille Chatelain, Lund University, SWEDEN
- The Role of ILC2 in Tissue Homeostasis and Neoplasia
Tim Halim, Cancer Research UK Cambridge Institute, THE UNITED KINGDOM
Cancer Neuroscience
- Latent Neuropathy in Colorectal Cancer: Implications for Cancer Survivorship
Andrew Shepherd, University of Texas MD Anderson Cancer Center, THE USA
- Remodelling of the Bone Microenvironment During Cancer Infiltration: Insights from Multiplex Imaging and Spatial Transcriptomics
Christina Møller Andreasen, University of Southern Denmark, DENMARK
- Enteric Nervous System-Derived VIP Restrains Differentiation of LGR5+ Stem Cells Towards the Secretory Lineage Impeding Type 2 Immune Programs
Christoph Klose, Charité – Berlin University Medicine, GERMANY
Cancer Therapy
- Targeting the Dark Matter of Cancer with AI-Designed Mini Binder
Tobias Bald, University of Bonn, DEUTSCHLAND
- Engineering Nanomedicines for Targeted Neuroimmune Modulation
Helena Florindo, University of Lisbon, PORTUGAL
- Potentiating Immunotherapy of Urological Cancers with Oncolytic Viruses
Gabri van der Pluijm, Leiden University Medical Center, THE NETHERLANDS
- Cancer Neuroscience of Brain Tumors: From Basic Discoveries to Clinical TrialsKEYNOTE SPEAKER
Frank Winkler, Universitätsklinik Heidelberg, DEUTSCHLAND
- TBC
Sheeba Irshad, King’s College London, THE UNITED KINGDOM
- The War Against Glioblastoma Needs More Than Standard of Care
Stefaan Van Gool, IOZK Immun-Onkologisches Zentrum Köln, DEUTSCHLAND
- Uncovering the Spatial Regulation of γδ T Cells: Toward Receptor-Guided Immunotherapy
Jürgen Kuball, University Medical Center Utrecht, THE NETHERLANDS
- Latest Advances in CAR‑T Therapy in Lymphoma: Where Are We and Where Are We Going?
Jarosław Dybko, Lower Silesian Oncology Center in Wroclaw, POLAND
- Expanding CAR Targets to Non Protein Antigens
Sébastien Wälchli, Oslo University Hospital, NORWAY
- TBC
Helen Kakkassery, King’s College London, THE UNITED KINGDOM
PORT for Business — Company Session
- TBC
Malwina Woźniak, Łukasiewicz – PORT, POLAND
- TBC
Mariusz Olejniczak, WPD Pharmaceuticals, POLAND
- The Development of USP7 Inhibitor for Cancer Immunotherapy
Zbigniew Zasłona, Molecule, POLAND
- TBC
Milena Mazan, Ryvu Therapeutics, POLAND
- TBC
Marek Kudła, Ardigen, POLAND
- TBC
Mateusz Psurski, Biotechna, POLAND